Published in
Wiley Open Access, Journal of Cellular and Molecular Medicine, p. no-no, 2010
DOI: 10.1111/j.1582-4934.2010.01078.x
Elsevier, Journal of the American College of Cardiology, 10(55), p. A19.E181, 2010
DOI: 10.1016/s0735-1097(10)60182-9
Links
- ORCID
- Wiley Open Access
- Elsevier
- [www.ncbi.nlm.nih.gov] | PDF
- [hdl.handle.net]
- [europepmc.org] | PDF
- [www.researchgate.net]
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application
,
Giuseppe Pugliese,
Vittoria Ionta,
Juan Carlos Chachques,
Francesco Angelini,
Massimo Ricci,
Joost Pg G. Sluijter,
Federica Papetti
and other authors.
Full text: Download
Abstract
Tissue engineering is an increasingly expanding area of research in the cardiovascular field that involves engineering, chemistry, biology and medicine. Cardiac tissue engineering (CTE) aims to regenerate myocardial damage by combining cells, matrix, biological active molecules and physiological stimuli. The rationale behind CTE applications is that in order to regenerate the ventricular wall after a myocardial infarction it is necessary to combine procedures that regenerate both cardiomyocytes and the extracellular matrix. The application of (stem) cells together with a matrix could represent an environment protected from the inflammatory and pro-apoptotic signals, a stemness/survival reservoir slowly releasing cells and factors promoting tissue regeneration and angiogenesis. This review will focus on the applications and advantages that CTE application could offer compared to conventional cell therapy.